U.S. Communications Stock News

Wondering if Live Nation Entertainment at around $128 a share is still worth the hype, or if most of the upside is already priced in? You are not alone. The stock has slipped about 1.9% over the last week, is down 14.2% over the past month and roughly flat year to date, but it is still sitting on hefty 3 year and 5 year gains of 80.7% and 82.9% that keep long term investors smiling. Recent headlines have revolved around regulatory scrutiny of ticketing practices and ongoing debate about...

If you are wondering whether Belite Bio's rapid rise is backed by real value or driven by hype, this article will walk you through what the numbers are really saying about the stock. After a sharp move higher, with the share price up 16.4% over the last week, 34.2% over the last month, and an eye catching 132.9% year to date, the market is clearly re rating the story and its risk profile. Much of the excitement has centered around Belite Bio's late stage ophthalmology pipeline, particularly...

Wondering if Graco at around $82 a share is a quiet bargain or a value trap in the making? This breakdown will walk you through what the current price is really telling us. Despite a modest slide of 0.5% over the last week and being down 8.2% over the past year, Graco still sits on a 27.0% return over 3 years and 29.4% over 5 years, which points to a longer term story beneath the recent softness. Recently, investors have been reacting to broader industrial and capital goods sector sentiment,...

Over the past year, many SPX Technologies, Inc. ( NYSE:SPXC ) insiders sold a significant stake in the company which...

Unfortunately for some shareholders, the Yueda Digital Holding ( NASDAQ:YDKG ) share price has dived 77% in the last...

If you have been wondering whether Central Garden & Pet at around $33.63 is quietly turning into a value opportunity or just a value trap, you are not alone. The stock is down about 11.8% year to date and 17.6% over the last year, even though it has managed positive annualized returns of roughly 10.5% over 3 years and 13.1% over 5 years, a mix that hints at both recovery potential and shifting risk sentiment. Recent headlines have focused on Central Garden & Pet sharpening its portfolio...

ORIC Pharmaceuticals is preparing to present new Phase 1b data for its brain-penetrant EGFR/HER2 inhibitor enozertinib (ORIC-114) in previously treated HER2 exon 20 mutant non-small cell lung cancer at the ESMO Asia Congress 2025 in Singapore, with a follow-up investor webcast on December 6, 2025. The upcoming data disclosure is important because it centers on a genetically defined, hard-to-treat lung cancer subset where targeted treatment options remain limited, making trial design details...

Vestis (VSTS) has wrapped up FY 2025 with fourth quarter revenue of about $712 million and a basic EPS of roughly -$0.10, capping off a trailing twelve month stretch that generated around $2.7 billion in sales and a basic EPS of about -$0.31. The company has seen quarterly revenue move from roughly $684 million in Q4 2024 to $712 million in Q4 2025. Over the same period, basic EPS shifted from about -$0.02 to roughly -$0.10, underscoring that the top line is holding up even as margins remain...

If you are wondering whether CRA International is still worth buying after its big multi year run or just coasting on past success, you are not alone. This piece unpacks what the current share price really implies. The stock has pulled back about 4.3% over the last month and is roughly flat year to date. Zooming out, it is still up 61.0% over 3 years and 272.1% over 5 years, which keeps growth minded investors interested even after a softer 12 month return of around 4.1%. Recent headlines...

If you are wondering whether Credo Technology Group Holding is still an attractive opportunity after its large run up, or if you have already missed the boat, you are in the right place to dig into what the current price really implies. The stock has surged 14.9% over the last week, 4.3% over the past month, and an eye catching 173.1% over the last year, with an even bigger 1146.3% gain over three years. This naturally raises questions about how much future growth is already reflected in the...

If you have ever wondered whether AXIS Capital Holdings is still a smart buy after its big run, you are in the right place. We are going to unpack what the current price really implies about future value. The stock has climbed 1.4% over the last week, 8.5% over the past month, and is now up 14.3% year to date, building on a 91.6% gain over 3 years and 123.8% over 5 years. Recent headlines around the insurance space have focused on shifting catastrophe risks, tighter underwriting standards,...

If you are wondering whether Ensign Group remains attractive after its recent run, or if you are arriving just as the value is fading, this breakdown aims to provide a clear, grounded view of what the stock may be worth. The share price has pulled back slightly in the short term, down 3.1% over the last week and 1.5% over the last month. It is still up 36.3% year to date and 24.6% over the past year, with gains of 97.9% over 3 years and 141.4% over 5 years that indicate a strong long-term...

As December 2025 unfolds, the U.S. stock market is experiencing a rebound with major indexes like the tech-heavy Nasdaq, blue-chip Dow Jones Industrial Average, and benchmark S&P 500 posting gains amid renewed investor confidence in tech and crypto-related stocks. In this dynamic environment, identifying promising small-cap stocks requires a keen understanding of market trends and insider actions that may signal potential opportunities for growth.

As of December 2025, the United States market has shown resilience with major indexes like the tech-heavy Nasdaq and blue-chip Dow Jones Industrial Average closing higher, fueled by a rebound in tech and crypto-related stocks. In this environment of renewed optimism, identifying high-growth tech stocks involves looking for companies that not only demonstrate robust financial performance but also have the potential to capitalize on emerging trends and technological advancements within a...

As of early December 2025, U.S. markets have shown resilience with major indexes closing higher amid a rebound in tech and crypto-related stocks. This environment presents opportunities for investors to explore stocks that may be trading below their fair value estimates, such as Lyft and others, by focusing on fundamental strengths and market positioning amidst the current economic landscape.

As the U.S. markets close higher with a rebound in tech and crypto-related stocks, investors are keenly observing opportunities across various sectors. Penny stocks, despite being an older term, continue to hold relevance for those seeking growth potential in smaller or newer companies. These stocks can offer significant returns when backed by strong financial health, making them an intriguing option for investors looking to uncover hidden value in quality companies.

As the United States markets experience a rebound, with major indexes such as the Nasdaq, Dow Jones Industrial Average, and S&P 500 closing higher amid a resurgence in tech and crypto-related stocks, investors are keenly observing opportunities for stable returns. In this environment of fluctuating market dynamics, dividend stocks offer potential appeal by providing consistent income streams; here we explore three dividend stocks with yields ranging up to 8%.

We'd be surprised if Arrowhead Pharmaceuticals, Inc. ( NASDAQ:ARWR ) shareholders haven't noticed that the Independent...

Motorcar Parts of America, Inc. ( NASDAQ:MPAA ) shareholders won't be pleased to see that the share price has had a...

Harte Hanks, Inc. ( NASDAQ:HHS ) shares have had a really impressive month, gaining 25% after a shaky period...

Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) shares have retraced a considerable 66% in the last month, reversing...

Despite an already strong run, Steven Madden, Ltd. ( NASDAQ:SHOO ) shares have been powering on, with a gain of 27% in...

Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) shares have had a horrible month, losing 35% after a relatively good...

Allegiant Travel Company ( NASDAQ:ALGT ) shareholders have had their patience rewarded with a 25% share price jump in...